Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282034604> ?p ?o ?g. }
- W4282034604 endingPage "887" @default.
- W4282034604 startingPage "876" @default.
- W4282034604 abstract "Epidemiologic studies have documented lower rates of active smokers compared to former or non-smokers in symptomatic patients affected by coronavirus disease 2019 (COVID-19). We assessed the efficacy and safety of nicotine administered by a transdermal patch in critically ill patients with COVID-19 pneumonia. In this multicentre, double-blind, placebo-controlled trial conducted in 18 intensive care units in France, we randomly assigned adult patients (non-smokers, non-vapers or who had quit smoking/vaping for at least 12 months) with proven COVID-19 pneumonia receiving invasive mechanical ventilation for up to 72 h to receive transdermal patches containing either nicotine at a daily dose of 14 mg or placebo until 48 h following successful weaning from mechanical ventilation or for a maximum of 30 days, followed by 3-week dose tapering by 3.5 mg per week. Randomization was stratified by centre, non- or former smoker status and Sequential Organ Function Assessment score (< or ≥ 7). The primary outcome was day-28 mortality. Main prespecified secondary outcomes included 60-day mortality, time to successful extubation, days alive and free from mechanical ventilation, renal replacement therapy, vasopressor support or organ failure at day 28. Between November 6th 2020, and April 2nd 2021, 220 patients were randomized from 18 active recruiting centers. After excluding 2 patients who withdrew consent, 218 patients (152 [70%] men) were included in the analysis: 106 patients to the nicotine group and 112 to the placebo group. Day-28 mortality did not differ between the two groups (30 [28%] of 106 patients in the nicotine group vs 31 [28%] of 112 patients in the placebo group; odds ratio 1.03 [95% confidence interval, CI 0.57–1.87]; p = 0.46). The median number of day-28 ventilator-free days was 0 (IQR 0–14) in the nicotine group and 0 (0–13) in the placebo group (with a difference estimate between the medians of 0 [95% CI -3–7]). Adverse events likely related to nicotine were rare (3%) and similar between the two groups. In patients having developed severe COVID-19 pneumonia requiring invasive mechanical ventilation, transdermal nicotine did not significantly reduce day-28 mortality. There is no indication to use nicotine in this situation." @default.
- W4282034604 created "2022-06-13" @default.
- W4282034604 creator A5000822953 @default.
- W4282034604 creator A5002223174 @default.
- W4282034604 creator A5002389648 @default.
- W4282034604 creator A5002743286 @default.
- W4282034604 creator A5004349009 @default.
- W4282034604 creator A5004476411 @default.
- W4282034604 creator A5004520435 @default.
- W4282034604 creator A5005934498 @default.
- W4282034604 creator A5006074019 @default.
- W4282034604 creator A5006705728 @default.
- W4282034604 creator A5006785100 @default.
- W4282034604 creator A5009408043 @default.
- W4282034604 creator A5010053376 @default.
- W4282034604 creator A5010598070 @default.
- W4282034604 creator A5011178135 @default.
- W4282034604 creator A5012669839 @default.
- W4282034604 creator A5013002748 @default.
- W4282034604 creator A5013206878 @default.
- W4282034604 creator A5015611967 @default.
- W4282034604 creator A5015655236 @default.
- W4282034604 creator A5016701155 @default.
- W4282034604 creator A5017203226 @default.
- W4282034604 creator A5017883658 @default.
- W4282034604 creator A5018007709 @default.
- W4282034604 creator A5018677121 @default.
- W4282034604 creator A5021962856 @default.
- W4282034604 creator A5023559190 @default.
- W4282034604 creator A5023571915 @default.
- W4282034604 creator A5024214171 @default.
- W4282034604 creator A5025956536 @default.
- W4282034604 creator A5026657678 @default.
- W4282034604 creator A5028936457 @default.
- W4282034604 creator A5029943377 @default.
- W4282034604 creator A5030665297 @default.
- W4282034604 creator A5032676052 @default.
- W4282034604 creator A5032851131 @default.
- W4282034604 creator A5034623450 @default.
- W4282034604 creator A5035000334 @default.
- W4282034604 creator A5035798028 @default.
- W4282034604 creator A5036507581 @default.
- W4282034604 creator A5036659884 @default.
- W4282034604 creator A5037061640 @default.
- W4282034604 creator A5037404312 @default.
- W4282034604 creator A5037542169 @default.
- W4282034604 creator A5037628493 @default.
- W4282034604 creator A5038534286 @default.
- W4282034604 creator A5039501435 @default.
- W4282034604 creator A5041068436 @default.
- W4282034604 creator A5041765089 @default.
- W4282034604 creator A5042051747 @default.
- W4282034604 creator A5042632008 @default.
- W4282034604 creator A5042999965 @default.
- W4282034604 creator A5043014300 @default.
- W4282034604 creator A5043032613 @default.
- W4282034604 creator A5043184350 @default.
- W4282034604 creator A5043754495 @default.
- W4282034604 creator A5044714000 @default.
- W4282034604 creator A5045678036 @default.
- W4282034604 creator A5045722338 @default.
- W4282034604 creator A5046498953 @default.
- W4282034604 creator A5047272673 @default.
- W4282034604 creator A5047693831 @default.
- W4282034604 creator A5049625807 @default.
- W4282034604 creator A5050554978 @default.
- W4282034604 creator A5051484421 @default.
- W4282034604 creator A5052265648 @default.
- W4282034604 creator A5052636813 @default.
- W4282034604 creator A5053741840 @default.
- W4282034604 creator A5056562108 @default.
- W4282034604 creator A5056628442 @default.
- W4282034604 creator A5058720144 @default.
- W4282034604 creator A5059045057 @default.
- W4282034604 creator A5060274960 @default.
- W4282034604 creator A5061230975 @default.
- W4282034604 creator A5062007652 @default.
- W4282034604 creator A5062319274 @default.
- W4282034604 creator A5063322291 @default.
- W4282034604 creator A5064880026 @default.
- W4282034604 creator A5066403448 @default.
- W4282034604 creator A5066459531 @default.
- W4282034604 creator A5066890185 @default.
- W4282034604 creator A5068048359 @default.
- W4282034604 creator A5069733466 @default.
- W4282034604 creator A5070071339 @default.
- W4282034604 creator A5070571289 @default.
- W4282034604 creator A5070982450 @default.
- W4282034604 creator A5071271766 @default.
- W4282034604 creator A5071301713 @default.
- W4282034604 creator A5071685074 @default.
- W4282034604 creator A5072547311 @default.
- W4282034604 creator A5073345978 @default.
- W4282034604 creator A5073654642 @default.
- W4282034604 creator A5074118919 @default.
- W4282034604 creator A5074191703 @default.
- W4282034604 creator A5074203143 @default.
- W4282034604 creator A5074248418 @default.